Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.

Saved in:
Bibliographic Details
Title: Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
Authors: Mia MM; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Cibi DM; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Ghani SABA; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Singh A; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Tee N; National Heart Research Institute Singapore, National Heart Centre Singapore, 169609Singapore., Sivakumar V; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Bogireddi H; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore., Cook SA; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore.; National Heart Research Institute Singapore, National Heart Centre Singapore, 169609Singapore., Mao J; Department of Molecular, Cell and Cancer Biology, Medical School, University of Massachusetts, Worcester, MA 01605, USA., Singh MK; Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 169857Singapore.; National Heart Research Institute Singapore, National Heart Centre Singapore, 169609Singapore.
Source: Cardiovascular research [Cardiovasc Res] 2022 Jun 22; Vol. 118 (7), pp. 1785-1804.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford Journals Country of Publication: England NLM ID: 0077427 Publication Model: Print Cited Medium: Internet ISSN: 1755-3245 (Electronic) Linking ISSN: 00086363 NLM ISO Abbreviation: Cardiovasc Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1755-3245
DOI:10.1093/cvr/cvab205